Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2019 Oct 1;142(10):2903-2904.
doi: 10.1093/brain/awz278.

Elevated tau PET signal depends on abnormal amyloid levels and is uncommon in unimpaired individuals

Brian A Gordon  1 , Betty M Tijms  2
Affiliations
Comment

Elevated tau PET signal depends on abnormal amyloid levels and is uncommon in unimpaired individuals

Brian A Gordon et al. Brain. .

Abstract

This scientific commentary refers to ‘The bivariate distribution of amyloid-β and tau: relationship with established neurocognitive clinical syndromes’, by Jack et al. (doi:10.1093/brain/awz268).

PubMed Disclaimer

Comment on

References

    1. Fagan AM, Mintun MA, Shah AR, Aldea P, Roe CM, Mach RH, et al. Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: implications for future clinical trials of Alzheimer’s disease. EMBO Mol Med 2009; 1: 371–80. - PMC - PubMed
    1. Gordon BA, Friedrichsen K, Brier M, Blazey T, Su Y, Christensen J, et al. The relationship between cerebrospinal fluid markers of Alzheimer pathology and positron emission tomography tau imaging. Brain 2016; 139: 2249–60. - PMC - PubMed
    1. Hardy J, De Strooper B. Alzheimer’s disease: where next for anti-amyloid therapies? Brain 2017; 140: 853–5. - PubMed
    1. Jack CR, Wiste HJ, Botha H, Weigand SD, Therneau TM, Knopman DS, et al. The bivariate distribution of amyloid-β and tau: relationship with established neurocognitive clincial syndromes. Brain 2019; 142: 3230–42. - PMC - PubMed
    1. Morris J, Price JL. Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer’s disease. J Mol Neurosci 2001; 17: 101–18. - PubMed